In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

Sales of Humira – used to treat a long list of diseases ... The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a ...

Humira volume is rapidly eroding compared to other novel mechanisms (including Skyrizi and Rinvoq). The decline expected to be sharper in 2025 as more plans exclude branded Humira and move to ...

Rova-T had a convincing-looking mechanism of action ... were in the region of $5 billion per year at peak. It wasn’t a Humira, but AbbVie was realistic enough to accept that it was unlikely ...

Dosage for Humira (adalimumab) may vary based on the condition it’s being used to treat. Also, your doctor may adjust your dosage over the course of your treatment. Be sure to take the Humira ...

As with other drugs, Humira (adalimumab) can cause side effects, such as headache and injection site reactions. If you are not able to tolerate side effects of Humira, talk with your doctor or ...

Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...